Advertisement
Singapore markets open in 1 hour 1 minute

  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • Dow

    38,460.92
    -42.77 (-0.11%)
     

  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     

  • Bitcoin USD

    64,263.63
    -2,139.52 (-3.22%)
     

  • CMC Crypto 200

    1,385.96
    -38.14 (-2.68%)
     

  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     

  • Gold

    2,328.70
    -9.70 (-0.41%)
     

  • Crude Oil

    82.83
    +0.02 (+0.02%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     

  • Jakarta Composite Index

    7,174.53
    -7,110.81 (-49.78%)
     

  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

uniQure (QURE) in Focus: Stock Moves 11.9% Higher

Zacks Equity Research
Updated

uniQure N.V. QURE was a big mover last session, as the company saw its shares rise nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent trend for the company—as the stock is now up 44.4% in the past one-month time frame.

The company has seen no estimate revisions over the past one month, and the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future. 

uniQure currently has a Zacks Rank #4 (Sell) while its Earnings ESP  is 0.00%.

uniQure N.V. Price and Consensus

uniQure N.V. Price and Consensus | uniQure N.V. Quote

ADVERTISEMENT

A better-ranked stock in the Medical - Biomedical and Genetics  industry is Axovant Sciences Ltd. AXON, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is QURE going up? Or down? Predict to see what others think: Up or Down

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.  

See the pot trades we're targeting>>                                    


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Axovant Sciences Ltd. (AXON) : Free Stock Analysis Report
 
uniQure N.V. (QURE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research